13F Insight
DOSSIER · 13F-HR · Q4 2025

Elmind Capital, LP

Elmind's holding co. based in San Francisco, CA — $339M in tracked AUM across 34 positions as of Q4 2025.

E
Elmind·San Francisco, CA·Holding Co.
CIK 0002052213 · last filed Dec 31, 2025
Total AUM
$339M
▲ 9.2%
vs prior
Holdings
34
—
positions
Whale Score
44
44
tracked
Activity
—
no data
changes this Q
Top sector
Health Care
20% weight
concentration
AI Analysis · Q4 2025 · Q4 2025

Elmind Capital, LP filed its latest 13F-HR for Q4 2025. See the latest holdings and position changes below.

Quarter at a glance — Q4 2025

Position-change comparison pending.

No quarter-over-quarter changes available.

Top 10 holdings

By portfolio weight as of Q4 2025.

#HoldingValueSharesWeight
01
COGT
COGENT BIOSCIENCES INC
$42M1.2M12.3%
02
SNDX
SYNDAX PHARMACEUTICALS INC
$39M1.9M11.5%
03
VRDN
VIRIDIAN THERAPEUTICS INC
$27M859K7.9%
04
VERA
VERA THERAPEUTICS INC
$24M483K7.2%
05
CLDX
CELLDEX THERAPEUTICS INC NEW
$23M865K6.9%
06
CGON
CG ONCOLOGY INC
$20M493K6.0%
07
BCRX
BIOCRYST PHARMACEUTICALS INC
$17M2.1M4.9%
08
PCVX
VAXCYTE INC
$13M292K4.0%
09
BEAM
BEAM THERAPEUTICS INC
$13M476K3.9%
10
N69605108
PHARVARIS N V
$13M476K3.9%

Filing history

Filing history loading…